Fact CheckerSign in

NCT06806059Recruiting

Preoperative Physical Activity Before Radical Cystectomy and the Impact on Morbidity

Prospective Randomized Interventional Study to Investigate the Impact of Preoperative Physical Activity on Perioperative Morbidity Following Radical Cystectomy

Source: ClinicalTrials.gov · Last updated 27 Apr 2026

Brief summary (registry, in English)

Bladder cancer (BC) is the 6th most common tumor in Europe, with over 540,000 new cases globally each year. While 75% of cases are non-muscle-invasive and treated bladder-preservingly, muscle-invasive, non-metastatic BC requires radical cystectomy (RC), often with neoadjuvant chemotherapy. RC has one of the highest complication rates in urology, and rehabilitation focuses on mitigating functional impairments, restoring physical and mental capacity, and enabling a swift return to daily life. The ERAS (Enhanced Recovery After Surgery) protocol has shown benefits in reducing hospital stays without increasing complications in RC. Prehabilitation studies in cancer patients have demonstrated improvements in strength and fitness, though without significant reductions in complications or mortality. This prospective randomized study, conducted over three years at the University of Munich, will evaluate the effect of preoperative physical activity on perioperative morbidity (primary endpoint). Secondary endpoints include quality of life, hospital stay, mortality, and postoperative physical activity. The intervention group will target 8,000-10,000 daily steps for four weeks preoperatively, monitored via pedometers. Follow-ups will assess physical activity and quality of life at specific intervals pre- and post-surgery.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
146 (estimated)
First submitted
15 Jan 2025
Start date
29 Nov 2024
Primary completion date
29 Nov 2026
Lead sponsor
Ludwig-Maximilians - University of Munich
NCT number
NCT06806059

What you commit to

  • Study type: Interventional
  • Planned participants: 146
  • From 29 Nov 2024 to the primary completion date, 29 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Time to surgery \< 3 Weeks

Other illness

  • cardiovascular, neuromuscular or orthopaedic deficites / disorders

Other

  • Need for walking aid
  • Depression

Who the study is looking for

  • Urothelial cell cancer of the bladder
  • Treatment with radical cystectomy

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Urology, LMU Hospital
Coordinator of this site? Confirm its status
MunichGermanyRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.